Hyaluronic Acid
DeviceInjectable gel for lip augmentation
Other names: Restylane Kysse
NCT Number: NCT03967444
Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Kysse.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Galderma Study Site, Montreal, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Injectable gel for lip augmentation
Other names: Restylane Kysse
Time frame: 8 weeks after last treatment
The 5-grade Global Aesthetic Improvement Scale (GAIS) assess the appearance of the lips compared to pre-treatment. The rating is very much improved, much improved, improved, no change, or worse. Responders are those with a rating of at least improved.
Galderma R&D
Industry
Post Marketing Study to Evaluate Lip Augmentation & Satisfaction With Restylane Kysse
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06961305
Aesthetic, Lip Augmentation
Katowice, Poland
View Trial DetailsNCT05342753
Lip Augmentation
Los Angeles, California, United States
View Trial DetailsNCT06858007
Lip Augmentation
Timișoara, Timiș County, Romania
View Trial DetailsNCT04540913
Lip, Lip Augmentation
Bradenton, Florida, United States
View Trial Details